342 related articles for article (PubMed ID: 21092522)
21. Efficacy of two dose regimes of intravenous immunoglobulin in Rh hemolytic disease of newborn--a randomized controlled trial.
Girish G; Chawla D; Agarwal R; Paul VK; Deorari AK
Indian Pediatr; 2008 Aug; 45(8):653-9. PubMed ID: 18723908
[TBL] [Abstract][Full Text] [Related]
22. Neonatal hyperbilirubinemia due to ABO incompatibility: does blood group matter?
Akgül S; Korkmaz A; Yiğit S; Yurdakök M
Turk J Pediatr; 2013; 55(5):506-9. PubMed ID: 24382531
[TBL] [Abstract][Full Text] [Related]
23. Indication of Mild Hemolytic Reaction Among Preterm Infants With ABO Incompatibility.
Yogev-Lifshitz M; Leibovitch L; Schushan-Eisen I; Taran C; Strauss T; Maayan-Metzger A
Pediatr Blood Cancer; 2016 Jun; 63(6):1050-3. PubMed ID: 26841084
[TBL] [Abstract][Full Text] [Related]
24. Neonatal administration of high-dose intravenous immunoglobulin in rhesus hemolytic disease.
Voto LS; Sexer H; Ferreiro G; Tavosnanska J; Orti J; Mathet ER; Margulies M; Margulies M
J Perinat Med; 1995; 23(6):443-51. PubMed ID: 8904473
[TBL] [Abstract][Full Text] [Related]
25. Morbidity of ABO haemolytic disease in the newborn.
Bhat YR; Kumar CG
Paediatr Int Child Health; 2012 May; 32(2):93-6. PubMed ID: 22595217
[TBL] [Abstract][Full Text] [Related]
26. Single versus multiple dose intravenous immunoglobulin in combination with LED phototherapy in the treatment of ABO hemolytic disease in neonates.
Demirel G; Akar M; Celik IH; Erdeve O; Uras N; Oguz SS; Dilmen U
Int J Hematol; 2011 Jun; 93(6):700-703. PubMed ID: 21617887
[TBL] [Abstract][Full Text] [Related]
27. Metalloporphyrins for treatment of unconjugated hyperbilirubinemia in neonates.
Suresh GK; Martin CL; Soll RF
Cochrane Database Syst Rev; 2003; (2):CD004207. PubMed ID: 12804504
[TBL] [Abstract][Full Text] [Related]
28. Necrotizing enterocolitis in a newborn following intravenous immunoglobulin treatment for haemolytic disease.
Kara S; Ulu-ozkan H; Yilmaz Y; Arikan FI; Dilmen U; Bilge YD
J Coll Physicians Surg Pak; 2013 Aug; 23(8):598-600. PubMed ID: 23930883
[TBL] [Abstract][Full Text] [Related]
29. [Neonatal ABO incompatibility underlies a potentially severe hemolytic disease of the newborn and requires adequate care].
Senterre T; Minon JM; Rigo J
Arch Pediatr; 2011 Mar; 18(3):279-82. PubMed ID: 21255989
[TBL] [Abstract][Full Text] [Related]
30. [Phototherapy and infusion therapy of hemolytic diseases of the newborn due to rhesus factor incompatibility].
Leshkevich IA; Dobronravov AV; Kalashnikova TI; Semenkova AS
Vopr Okhr Materin Det; 1979 Jun; 24(6):15-9. PubMed ID: 112781
[No Abstract] [Full Text] [Related]
31. Prediction of ABO hemolytic disease of the newborn using pre- and perinatal quantification of maternal anti-A/anti-B IgG titer.
Krog GR; Donneborg ML; Hansen BM; Lorenzen H; Clausen FB; Jensen KV; Kjærbye-Thygesen A; Albertsen P; Ebbesen F; Bergholt T; Smed MK; Dziegiel MH
Pediatr Res; 2021 Jul; 90(1):74-81. PubMed ID: 33173174
[TBL] [Abstract][Full Text] [Related]
32. [Comparison of Therapeutic Efficacy for Neonatal ABO Hemolytic Disease Treated with Intravenous Immunoglobin G by Different Modes of Administration].
Liu YF; Zou CC; Yang HQ; Lou LJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2016 Dec; 24(6):1842-1845. PubMed ID: 28024505
[TBL] [Abstract][Full Text] [Related]
33. Three or four doses of intravenous immunoglobulin G treatment for isoimmune hemolytic disease: A case series and literature review.
Zheng Y; Almeyda-Alejo Y; Tumin D; Redpath NSJ; Guillen-Hernandez J
J Neonatal Perinatal Med; 2024; 17(1):153-158. PubMed ID: 38143377
[TBL] [Abstract][Full Text] [Related]
34. Efficacy of intravenous immunoglobulin in the management of haemolytic disease of the newborn.
Walsh SA; Yao N; El-Khuffash A; Twomey A; Molloy EJ
Ir Med J; 2008 Feb; 101(2):46-8. PubMed ID: 18450249
[TBL] [Abstract][Full Text] [Related]
35. Intravenous immune globulin reduces the need for exchange transfusions in Rhesus and AB0 incompatibility.
Huizing K; Røislien J; Hansen T
Acta Paediatr; 2008 Oct; 97(10):1362-5. PubMed ID: 18616629
[TBL] [Abstract][Full Text] [Related]
36. Routine administration of intravenous calcium during exchange blood transfusion for treatment of severe neonatal hyperbilirubinaemia: a systematic review of quantitative evidence protocol.
Orimadegun AE; Akingbola TS
JBI Database System Rev Implement Rep; 2015 Jan; 13(1):134-45. PubMed ID: 26447014
[TBL] [Abstract][Full Text] [Related]
37. Intravenous Immunoglobulin therapy for anti-E hemolytic disease in the newborn.
Onesimo R; Rizzo D; Ruggiero A; Valentini P
J Matern Fetal Neonatal Med; 2010 Sep; 23(9):1059-61. PubMed ID: 20092394
[TBL] [Abstract][Full Text] [Related]
38. Intravenous immunoglobulin in hemolytic disease of the newborn: A moving target in time.
Vardar G; Okan MA; Karadag N; Topcuoglu S; Ozalkaya E; Karatepe HO; Karatekin G
Niger J Clin Pract; 2022 Aug; 25(8):1262-1268. PubMed ID: 35975373
[TBL] [Abstract][Full Text] [Related]
39. Rhesus isoimmunization: increased hemolysis during early infancy.
Hayde M; Widness JA; Pollak A; Kohlhauser-Vollmuth C; Vreman HJ; Stevenson DK
Pediatr Res; 1997 May; 41(5):716-21. PubMed ID: 9128296
[TBL] [Abstract][Full Text] [Related]
40. [Hemolytic disease of the newborn due to ABO incompatibility (author's transl)].
Fischer K; Poschmann A; Grundmann A
Z Geburtshilfe Perinatol; 1977 Aug; 181(4):227-40. PubMed ID: 410177
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
